IRD vs SOPH

The company exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. Most alarming is the negative gross margin of -117.05%, meaning the company loses money on every unit of revenue generated before operating expenses. Despite a speculative 654.9% price surge over the last year and a 'strong_buy' analyst consensus, the underlying data shows declining revenue (-10.20%) and extreme valuation multiples (P/B of 24.36). The stock appears to be trading on momentum or speculative expectations rather than any tangible financial health.

SOPH exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a profit margin of -102.24%. While the company maintains a strong gross margin (67.39%) and healthy revenue growth (22.40%), these are overshadowed by massive operational losses and a bearish insider sentiment. The disconnect between the 'Strong Buy' analyst consensus and the deteriorating fundamental health suggests a highly speculative valuation. Overall, the company is burning capital rapidly with no clear path to profitability in the immediate term.